MethodologyAbout
Search
Menu
GCC · ADX IHC

IHC (IHC) financial statements: income, balance sheet and cash flow

ADX: IHC · Industrials · United Arab Emirates

Signed off by OffScriptBySami on  · Updated

Data as of  · For information only, not investment advice.

In brief

IHC (ADX: IHC) earned net income attributable to owners of AED 12.8 billion on revenue of AED 33.4 billion in Q2 2026, the quarter ended 30 Jun 2026, according to its interim financial statements. Total debt stood at AED 99.1 billion and cash and bank balances at AED 72.9 billion at 30 Jun 2026.

Data as of Source: Interim financial statements for H1 2026, approved

Key facts

Data as of

IHC (ADX: IHC) · AED · fiscal year ends 31 December · figures from the company's financial statements; derived values are marked.

Net income, TTM (AED bn)
34.2
TTM to · derived
Total assets (AED bn)
470
at · the company's financial statements
Net debt (AED bn)
26.2
at · derived: total debt minus cash and short-term investments

What the numbers show

IHC's income statement for Q2 2026, the quarter ended 30 Jun 2026, shows revenue of AED 33.4 billion, up 35.8% on the re-presented Q2 2025. Gross profit was AED 8.85 billion, a gross margin of 26.5%, our calculation. Net income attributable to owners was AED 12.8 billion, a net margin of 38.4%, our calculation, which includes investment and other income that are not part of revenue.

Q1 2025 and Q2 2025 are re-presented in the 2026 reports, and Q3 2025 and Q3 2024 are as printed in the nine-month 2025 report. The quarterly table therefore mixes two bases and has no fourth-quarter column. Net income includes discontinued operations in the periods that had them, and investment and other income, so the net margin reflects items outside revenue.

Over the annual run, revenue rose from AED 28.6 billion in FY2021 to AED 60.1 billion in FY2023. FY2024 and FY2025 revenue is on a continuing-operations basis, while FY2023 and earlier revenue is as first printed. Growth from FY2023 to FY2024 therefore compares two bases. Net income was AED 21.7 billion in FY2025, AED 15.8 billion in FY2024 and AED 27.5 billion in FY2023.

IHC's balance sheet held total assets of AED 470 billion at 30 Jun 2026, against AED 429 billion at the end of FY2025. Cash and bank balances, which include term deposits and restricted cash, were AED 72.9 billion. Total debt, combined by the page from borrowings, sukuks and hybrid notes, was AED 99.1 billion, so net debt, our calculation, was AED 26.2 billion. Net debt was AED 8.80 billion at the end of FY2025.

In IHC's cash flow statement for Q1 2026, cash from operations was AED 2.61 billion and capital expenditure, additions to property, plant and equipment only, AED 964 million. Free cash flow, our calculation, was AED 1.65 billion. Q2 2026 cash from operations was an outflow of AED 22 million, and free cash flow an outflow of AED 1.33 billion. An interim report gives cash flows year to date, so the Q2 cells are our derivations, marked D.

Diluted EPS was AED 5.89 per share in Q2 2026, against AED 1.82 per share in Q2 2025. The diluted count was 2,181 million shares against 2,187 million shares. IHC bought back AED 3.80 billion of shares in FY2025 and AED 200 million in Q2 2026. IHC stock fundamentals sets out quarterly revenue, net debt and the restated income lines.

Income statement

Chart 1

IHC quarterly revenue, Q3 2024 to Q2 2026

AED bn · quarters ended to

Revenue by quarter, from AED 22.2 bn in Q3 2024 to AED 33.4 bn in Q2 2026.010203040RR33.4Q32024Q12025Q2Q3Q12026Q2stockfactsheet.com
Source: IHC financial statements Data as of

Annual

Report an error in this table
Download CSV

Swipe for earlier periods

Table 1 IHC income statement, annual, FY2021–FY2025 (AED millions) AED millions, except per-share data (AED) and percentages · Fiscal year ends 31 December
AED mFY2025ended FY2024ended FY2023ended FY2022ended FY2021ended CAGRFY21–FY25
Revenue111,40186,315 R60,08950,94628,562increased 40.5%
Revenue YoY %increased 29.1% Rincreased 43.6% Rincreased 17.9%increased 78.4%increased 305.3%not available
Cost of revenue82,27866,039 R47,04939,26918,387 Rincreased 45.4%
Gross profit29,12320,276 R13,04011,67710,176 Rincreased 30.1%
Gross margin %26.1%23.5% R21.7%22.9%35.6% Rnot available
SG&A12,422 D8,166 R D6,621 D8,047 R D2,373 Dincreased 51.3%
Pre-tax income34,43221,615 R33,81032,66011,590increased 31.3%
Income tax2,024888 R8568913increased 255.9%
Net income21,71515,76627,52312,6537,339increased 31.2%
Net margin %19.5%18.3% R45.8%24.8%25.7%not available
Per share
Diluted EPS (AED)9.937.1912.556.814.03increased 25.3%
Diluted shares (m)2,1872,194 R2,1941,8591,821not available
(opens in new tab)

Source: IHC financial statements Data as of

  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 92,658 m in IHC financial statements approved .
  • R Uses FY2024 revenue as restated or reclassified in IHC financial statements approved (AED 86,315 m; originally reported AED 92,658 m in IHC financial statements approved ).
  • R Uses FY2024 revenue as restated or reclassified in IHC financial statements approved (AED 86,315 m; originally reported AED 92,658 m in IHC financial statements approved ).
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 71,483 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 18,395 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 21,175 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 10,167 m in IHC financial statements approved .
  • R Uses FY2024 gross profit as restated or reclassified in IHC financial statements approved (AED 20,276 m; originally reported AED 21,175 m in IHC financial statements approved ).
  • R Uses FY2024 revenue as restated or reclassified in IHC financial statements approved (AED 86,315 m; originally reported AED 92,658 m in IHC financial statements approved ).
  • R Uses FY2021 gross profit as restated or reclassified in IHC financial statements approved (AED 10,176 m; originally reported AED 10,167 m in IHC financial statements approved ).
  • D Combined from line items reported in the same filing (see Methodology).
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 9,239 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 8,225 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 26,674 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 973 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported 2,193 m shares in IHC financial statements approved .
  • Not available

CAGR: compound annual growth rate from FY2021 to FY2025, our calculation; n/m when the endpoints differ in sign or the base is zero or negative.

Totals may not add up because of rounding.

Arrows show direction of change only, not whether a change is good or bad.

Quarterly

Report an error in this table
Download CSV

Swipe for earlier periods

Table 2 IHC income statement, quarterly, Q3 2024–Q2 2026 (AED millions) AED millions, except per-share data (AED) and percentages · Fiscal year ends 31 December
AED mQ2 2026ended Q1 2026ended Q3 2025ended Q2 2025ended Q1 2025ended Q3 2024ended
Revenue33,41131,44529,90224,610 R23,609 R22,215
Revenue YoY %increased 35.8% Rincreased 33.2% Rincreased 34.6%not availablenot availablenot available
Cost of revenue24,56023,52222,35818,574 R17,746 R17,073
Gross profit8,8507,9237,5446,036 R5,863 R5,143
Gross margin %26.5%25.2%25.2%24.5% R24.8% R23.1%
SG&A3,760 D3,436 D3,601 D2,238 R D2,028 R D1,929 D
Pre-tax income19,0308,9949,3336,473 R3,527 R5,948
Income tax992807635575 R552 R263
Net income12,8435,0684,6723,9841,4723,657
Net margin %38.4%16.1%15.6%16.2% R6.2% R16.5%
Per share
Diluted EPS (AED)5.892.322.141.820.671.67
Diluted shares (m)2,1812,1812,1872,1872,1902,194
(opens in new tab)

Source: IHC financial statements Data as of

  • D Combined from line items reported in the same filing (see Methodology).
  • R Restated or reclassified
  • Not available

Totals may not add up because of rounding.

Arrows show direction of change only, not whether a change is good or bad.

Balance sheet

Annual

Report an error in this table
Download CSV

Swipe for earlier periods

Table 3 IHC assets, annual, FY2021–FY2025 (AED millions) AED millions
AED mFY2025at FY2024at FY2023at FY2022at FY2021at
Cash and short-term investments74,85955,21233,91937,23020,247
Receivables47,375 R45,122 R25,46126,14011,210 R
Inventory14,19642,95415,32213,001899
PP&E (net)31,56735,29120,88619,5029,334 R
Goodwill and intangibles26,79816,4999,94711,6162,443
Total assets428,602401,811264,275228,03488,980
(opens in new tab)

Source: IHC financial statements Data as of

  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 48,632 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 44,943 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 11,213 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 9,307 m in IHC financial statements approved .

Totals may not add up because of rounding.

Report an error in this table
Download CSV

Swipe for earlier periods

Table 4 IHC liabilities and shareholders' equity, annual, FY2021–FY2025 (AED millions) AED millions · net cash shown as a negative net debt
AED mFY2025at FY2024at FY2023at FY2022at FY2021at
Total debt83,654 D71,757 D48,473 R D39,949 D8,408 R D
Shareholders' equity154,657 D 1147,962 D 197,054 D 169,676 D 127,094
Net debt / (net cash)8,795 D16,545 D14,555 R D2,718 D−11,839 R D
(opens in new tab)

Source: IHC financial statements Data as of

  • D Total debt = short-term debt + long-term debt, from the same filing.
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 48,438 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 8,457 m in IHC financial statements approved .
  • D Combined from line items reported in the same filing (see Methodology).
  • D Net debt = total debt minus cash and short-term investments; a negative value is net cash.
  • R Uses FY2023 total debt as restated or reclassified in IHC financial statements approved (AED 48,473 m; originally reported AED 48,438 m in IHC financial statements approved ).
  • R Uses FY2021 total debt as restated or reclassified in IHC financial statements approved (AED 8,408 m; originally reported AED 8,457 m in IHC financial statements approved ).

1 Includes other equity instruments, such as hybrid instruments, which the statements present in equity next to the equity attributable to the owners of the Company.

Totals may not add up because of rounding.

Quarterly

Report an error in this table
Download CSV

Swipe for earlier periods

Table 5 IHC assets, quarterly, Q3 2024–Q2 2026 (AED millions) AED millions
AED mQ2 2026at Q1 2026at Q3 2025at Q2 2025at Q1 2025at Q3 2024at
Cash and short-term investments72,86474,72456,903not availablenot availablenot available
Receivables56,82649,28358,611not availablenot availablenot available
Inventory19,06017,73543,378not availablenot availablenot available
PP&E (net)32,45131,84939,157not availablenot availablenot available
Goodwill and intangibles27,23227,35524,497not availablenot availablenot available
Total assets469,667445,322462,141not availablenot availablenot available
(opens in new tab)

Source: IHC financial statements Data as of

  • Not available

Totals may not add up because of rounding.

Report an error in this table
Download CSV

Swipe for earlier periods

Table 6 IHC liabilities and shareholders' equity, quarterly, Q3 2024–Q2 2026 (AED millions) AED millions · net cash shown as a negative net debt
AED mQ2 2026at Q1 2026at Q3 2025at Q2 2025at Q1 2025at Q3 2024at
Total debt99,065 D94,044 D90,235 Dnot availablenot availablenot available
Shareholders' equity165,929151,614146,247 D 1not availablenot availablenot available
Net debt / (net cash)26,201 D19,320 D33,331 Dnot availablenot availablenot available
(opens in new tab)

Source: IHC financial statements Data as of

  • D Total debt = short-term debt + long-term debt, from the same filing.
  • D Combined from line items reported in the same filing (see Methodology).
  • D Net debt = total debt minus cash and short-term investments; a negative value is net cash.
  • Not available

1 Includes other equity instruments, such as hybrid instruments, which the statements present in equity next to the equity attributable to the owners of the Company.

Totals may not add up because of rounding.

Cash flow

Chart 2

IHC quarterly free cash flow, Q3 2024 to Q2 2026

AED bn · quarters ended to

Free cash flow by quarter, from AED 2.23 bn in Q3 2024 to AED −1.33 bn in Q2 2026.−4−20246−2.2−1.3Q32024Q12025Q2Q3Q12026Q2stockfactsheet.com
Source: IHC financial statements Data as of

Annual

Report an error in this table
Download CSV

Swipe for earlier periods

Table 7 IHC cash flow, annual, FY2021–FY2025 (AED millions) AED millions · outflows shown with a minus sign
AED mFY2025ended FY2024ended FY2023ended FY2022ended FY2021ended
Cash from operations19,44012,370 R7,258 R16,279 R12,686 R
Capital expenditure−5,606−6,287−3,864−5,361−932
Free cash flow13,834 D6,083 R D3,393 R D10,918 R D11,754 R D
Share buybacks−3,801−1,1990not availablenot available
Cash from investing−25,908−7,843 R−17,785−31,260 R678 R
Cash from financing2,82917,3213,844 R20,155 R358
(opens in new tab)

Source: IHC financial statements Data as of

  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 11,553 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 7,307 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 17,440 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 12,703 m in IHC financial statements approved .
  • D Free cash flow = cash from operations minus capital expenditure.
  • R Uses FY2024 cash from operations as restated or reclassified in IHC financial statements approved (AED 12,370 m; originally reported AED 11,553 m in IHC financial statements approved ).
  • R Uses FY2023 cash from operations as restated or reclassified in IHC financial statements approved (AED 7,258 m; originally reported AED 7,307 m in IHC financial statements approved ).
  • R Uses FY2022 cash from operations as restated or reclassified in IHC financial statements approved (AED 16,279 m; originally reported AED 17,440 m in IHC financial statements approved ).
  • R Uses FY2021 cash from operations as restated or reclassified in IHC financial statements approved (AED 12,686 m; originally reported AED 12,703 m in IHC financial statements approved ).
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED −7,026 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED −33,489 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 2,499 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 3,848 m in IHC financial statements approved .
  • R Restated or reclassified in IHC financial statements approved ; originally reported AED 21,222 m in IHC financial statements approved .
  • Not available

Totals may not add up because of rounding.

Quarterly

Report an error in this table
Download CSV

Swipe for earlier periods

Table 8 IHC cash flow, quarterly, Q3 2024–Q2 2026 (AED millions) AED millions · outflows shown with a minus sign
AED mQ2 2026ended Q1 2026ended Q3 2025ended Q2 2025ended Q1 2025ended Q3 2024ended
Cash from operations−22 D2,612−855 D6,349 D3,612not available
Capital expenditure−1,307 D−964−1,360 D−1,196 D−1,381not available
Free cash flow−1,329 D1,648 D−2,215 D5,153 D2,231 Dnot available
Share buybacks−200 D00 D0 D−1,621not available
Cash from investing3,679 D−2,383−8,883 D−4,793 D−5,137not available
Cash from financing1,991 D2,3363,280 D3,648 D110not available
(opens in new tab)

Source: IHC financial statements Data as of

  • D Quarter derived from year-to-date totals: the six- or nine-month figure minus the earlier quarters.
  • D Free cash flow = cash from operations minus capital expenditure.
  • Not available

Totals may not add up because of rounding.

Per share and dividends

Report an error in this table
Download CSV

Swipe for earlier periods

Table 9 IHC per-share data and dividends, annual, FY2021–FY2025 AED per share, split-adjusted · shares in millions
AEDFY2025ended FY2024ended FY2023ended FY2022ended FY2021ended
Basic EPS (AED)9.937.1912.556.814.03
Diluted EPS (AED)9.937.1912.556.814.03
Diluted shares (m)2,1872,194 R2,1941,8591,821
(opens in new tab)

Source: IHC financial statements Data as of

  • R Restated or reclassified in IHC financial statements approved ; originally reported 2,193 m shares in IHC financial statements approved .

Notes on these figures

  • R Restated or reclassified
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 92,658 m in IHC financial statements approved .
    • Uses FY2024 revenue as restated or reclassified in IHC financial statements approved (AED 86,315 m; originally reported AED 92,658 m in IHC financial statements approved ).
    • Uses FY2024 revenue as restated or reclassified in IHC financial statements approved (AED 86,315 m; originally reported AED 92,658 m in IHC financial statements approved ).
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 71,483 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 18,395 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 21,175 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 10,167 m in IHC financial statements approved .
    • Uses FY2024 gross profit as restated or reclassified in IHC financial statements approved (AED 20,276 m; originally reported AED 21,175 m in IHC financial statements approved ).
    • Uses FY2024 revenue as restated or reclassified in IHC financial statements approved (AED 86,315 m; originally reported AED 92,658 m in IHC financial statements approved ).
    • Uses FY2021 gross profit as restated or reclassified in IHC financial statements approved (AED 10,176 m; originally reported AED 10,167 m in IHC financial statements approved ).
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 9,239 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 8,225 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 26,674 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 973 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported 2,193 m shares in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 48,632 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 44,943 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 11,213 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 9,307 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 48,438 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 8,457 m in IHC financial statements approved .
    • Uses FY2023 total debt as restated or reclassified in IHC financial statements approved (AED 48,473 m; originally reported AED 48,438 m in IHC financial statements approved ).
    • Uses FY2021 total debt as restated or reclassified in IHC financial statements approved (AED 8,408 m; originally reported AED 8,457 m in IHC financial statements approved ).
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 11,553 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 7,307 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 17,440 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 12,703 m in IHC financial statements approved .
    • Uses FY2024 cash from operations as restated or reclassified in IHC financial statements approved (AED 12,370 m; originally reported AED 11,553 m in IHC financial statements approved ).
    • Uses FY2023 cash from operations as restated or reclassified in IHC financial statements approved (AED 7,258 m; originally reported AED 7,307 m in IHC financial statements approved ).
    • Uses FY2022 cash from operations as restated or reclassified in IHC financial statements approved (AED 16,279 m; originally reported AED 17,440 m in IHC financial statements approved ).
    • Uses FY2021 cash from operations as restated or reclassified in IHC financial statements approved (AED 12,686 m; originally reported AED 12,703 m in IHC financial statements approved ).
    • Restated or reclassified in IHC financial statements approved ; originally reported AED −7,026 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED −33,489 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 2,499 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 3,848 m in IHC financial statements approved .
    • Restated or reclassified in IHC financial statements approved ; originally reported AED 21,222 m in IHC financial statements approved .
  • D Derived by StockFactsheet
    • Combined from line items reported in the same filing (see Methodology).
    • Total debt = short-term debt + long-term debt, from the same filing.
    • Combined from line items reported in the same filing (see Methodology).
    • Net debt = total debt minus cash and short-term investments; a negative value is net cash.
    • Free cash flow = cash from operations minus capital expenditure.
    • Quarter derived from year-to-date totals: the six- or nine-month figure minus the earlier quarters.
  • Template: standard statement set (not bank or insurer).
  • Arrows show direction of change only, not whether a change is good or bad.

How we got these numbers

Every figure comes from IHC's published financial statements. Derived values are marked D and explained below.

Full method for this page
Source documents
Interim and annual financial statements (FY2021 to Q2 2026)
Period covered
6 quarters and 5 fiscal years
Calculations
TTM = sum of the last 4 quarters. Q4 = fiscal year minus the nine-month YTD. Margins = line item ÷ revenue. FCF = cash from operations − capital expenditure. CAGR = compound annual growth across the annual table.
Restatements
FY2024 revenue, an input of the FY2024 ratio, was restated or reclassified in IHC financial statements approved (originally AED 92,658 m). FY2024 gross profit, an input of the FY2024 ratio, was restated or reclassified in IHC financial statements approved (originally AED 21,175 m). FY2021 gross profit, an input of the FY2021 ratio, was restated or reclassified in IHC financial statements approved (originally AED 10,167 m). FY2023 total debt, an input of the FY2023 ratio, was restated or reclassified in IHC financial statements approved (originally AED 48,438 m). FY2021 total debt, an input of the FY2021 ratio, was restated or reclassified in IHC financial statements approved (originally AED 8,457 m). FY2024 cash from operations, an input of the FY2024 ratio, was restated or reclassified in IHC financial statements approved (originally AED 11,553 m). FY2023 cash from operations, an input of the FY2023 ratio, was restated or reclassified in IHC financial statements approved (originally AED 7,307 m). FY2022 cash from operations, an input of the FY2022 ratio, was restated or reclassified in IHC financial statements approved (originally AED 17,440 m). FY2021 cash from operations, an input of the FY2021 ratio, was restated or reclassified in IHC financial statements approved (originally AED 12,703 m). Restated or reclassified figures carry the R marker; its footnote gives the originally reported value.
Comparator
None: this page shows the company's own figures only.
Currency
As reported (AED); no FX conversion.
Re-keying
Figures keyed from the issuer's published statements (PDF) with our entry tool, then checked by code against the PDF's own text (the figure on its cited page, in the row with its printed label) and by our fact-check step. The column and the sign are recorded, and lists any mismatch for review.
Read the full methodology

CSV downloads

One file per statement, with the annual and quarterly figures on this page in full units.

Sources and data

Data as of Figures are as reported in the filings below. Derived figures are our calculations (see Methodology).

(opens in new tab)
  1. [1] Issuer statement IHC interim financial statements, H1 2026 International Holding Company PJSC · approved · ihccms.directus.app
  2. [2] Issuer statement IHC interim financial statements, Q1 2026 International Holding Company PJSC · approved · ihccms.directus.app
  3. [3] Issuer statement IHC annual financial statements, FY2025 International Holding Company PJSC · approved · ihccms.directus.app
  4. [4] Issuer statement IHC interim financial statements, M9 2025 International Holding Company PJSC · approved · ihccms.directus.app
  5. [5] Issuer statement IHC annual financial statements, FY2024 International Holding Company PJSC · approved · ihccms.directus.app
  6. [6] Issuer statement IHC annual financial statements, FY2023 International Holding Company PJSC · approved · ihccms.directus.app
  7. [7] Issuer statement IHC annual financial statements, FY2022 International Holding Company PJSC · approved · ihccms.directus.app
  8. [8] Issuer statement IHC annual financial statements, FY2021 International Holding Company PJSC · approved · ihccms.directus.app
  9. [9] Our dataset Keyed from IHC's Q2 2026 financial statements (PDF) and checked by code against the PDF's text; signed off on .

Spotted an error? Report it Corrections log Methodology

Cite this page

StockFactsheet (2026). "IHC (IHC) financial statements: income, balance sheet and cash flow." Signed off by OffScriptBySami. Updated ; data as of . https://stockfactsheet.com/stocks/ihc-adx/financials/

Not investment advice

For information only. StockFactsheet does not recommend buying, selling or holding any security. Figures can contain errors; always check the original filings. Full disclaimer

Author and editor

Signed off by OffScriptBySami on · How pages are checked

StockFactsheet is not a licensed investment adviser, broker or dealer, and does not give personal recommendations.

How this page was made
  1. Data imported (the issuer's statements, )
  2. Drafted from our dataset only
  3. Automated checks and review steps passed ()
  4. Signed off and published by OffScriptBySami (, GST)

Update history

  1. Published First published version.